-/-mouse astrocytes in vitro. 50,000 of various cells with similar passage numbers were seeded in triplicate wells of 6-well plates, counted every three days, and re-seeded. Population doubling was calculated by dividing the total cell number by 50,000 and converting it to a log 2 value. No significant difference in cell proliferation was found among these cells. (B) Viability of Ink4a/Arf -/-mouse astrocytes in vitro. 3,000 of various cells were seeded in triplicate wells of a 96-well plate, followed by a 48-hour serum starvation. The number of viable cells was estimated using the WST-1 reagent and presented as a percentage to the number of viable PDGFRα/-A cells. Data are shown as mean ± s.d. *, P < 0.001, one-way ANOVA followed by NewmanKeuls post hoc test. -/-mAst expressing PDGFRα or PDGFRα/p19ARF were serum-starved for 24 hours followed by incubation with cisplatin (CDDP) at indicated concentrations for an additional 24 hours. Cells were then lysed for IB analyses. Cisplatin was able to induce p53 expression at a concentration of 10 μg/ml for U87MG and 20 μg/ml for Ink4a/Arf -/-mAst expressing PDGFRα/p19ARF. β−actin proteins were used as loading control. (B) An equal number of PDGFRα or PDGFRα/p19ARF-expressing Ink4a/Arf -/-mAst were cultured in triplicate wells in the presence of DMSO, 10 μg/ml, or 20 μg/ml CDDP for 48 hours before Trypan Blue exclusion assay for cell viability. *, P < 0.01; **, P < 0. to PDGFRα and downstream Akt phosphorylation in NIH3T3 cells were only moderately affected by SHP-2 knockdown. IB analysis of NIH3T3 mouse fibroblasts that were transfected with control or SHP-2 siRNA for 48 hours, serum-starved for an additional 24 hours followed by 50 ng/ml PDGF-A stimulation. Various whole-cell lysates or immunoprecipitates pulled down by an anti-PDGFRα antibody were subjected to IB analysis using indicated antibodies. Corresponding total proteins, β-actin, or total pulled-down IgG were used as loading controls for induced protein phosphorylation (2) or associations (IP followed by IB). (B) Ink4a/Arf -/-EGFRvIII mAst, LN444/EGFRvIII, and U87MG/EGFRvIII cells were transfected with control or SHP-2 siRNA for 48 hours, and then lysed for IB analysis using indicated antibodies. β-actin was used as a loading control. 
Supplemental Experimental Procedures

Antibodies and Reagents
The following antibodies and reagents were used in this study: rabbit anti-PDGFRα (sc-338, (#565851) (6) and MEK inhibitor PD98059 were from EMD Chemicals, Gibbstown, NJ; PHPS-p16INK4a and pMIEG3-egfp-p19ARF were used. For shRNA experiments, the lentiviral vectors pLKO.1-shCDKN2A (6 clones) and pLKO.1-shPTPN11 (5 clones) were purchased from Thermo Scientific, Huntsville, AL.
Retroviruses and lentiviruses were produced by co-transfecting various cDNA and packaging plasmids into 293T or Phoenix TM (Orbigen Inc., San Diego, CA) cells using Lipofectamine 2000 TM reagent according to manufacturer's instruction (#52758, Invitrogen). Forty-eight hours after transfection, the supernatants containing viruses were filtered by a 0.45-μm syringe filter (Fisher) and added into the culture media supplemented with 8 μg/ml polybrene. Forty-eight hours after the infection, transduced human glioma cells or primary astrocytes were harvested and re-plated in DMEM containing 10% FBS and 2 μg/ml puromycin or 300 μg/ml hygromycin for drug selection or sorted by Fluorescence-activated Cell Sorting (FACS) for GFP expression.
Expression of exogenous PDGFRα and its various mutants in the resultant cell populations was validated by immunoblotting (IB) and GFP expression by FACS.
RT-PCR
Total RNAs from various human glioma cell lines were extracted using RNeasy Mini Kit 
Mouse glioma Xenografts
Experiments of glioma xenografts were performed as previously described (11) . For intracranial glioma xenograft experiments, human glioma cells or mAst were harvested and re-suspended at 
Cell Proliferation and Viability Assays
Cell proliferation and viability were determined as previously described (12) . Briefly, 50,000 cells were seeded in 10% FBS / DMEM, split, counted, and re-seeded every 3 days in a 6-well plate. Population doubling was calculated by dividing the total cell number by the cells seeded (50,000 cells), using log 2 versus the days in culture to determine the proliferation rate of each type of cells.
Cell viability was assessed by a colorimetric assay using a WST-1 reagent (Roche)
according to manufacturer's instruction. Briefly, 3000 cells were seeded in triplicate wells of a 96-well microplate and incubated in a serum-free medium for 48 hours at 37°C and 5% CO 2 . A WST-1 reagent was then added to the media (10 μl/well) and incubated for an additional 2 hours.
Light absorption of samples in each well was measured at a wavelength of 450 nm in a ThermoMax microplate reader (Molecular Devices, Sunnyvale, CA). Wells containing only culture media were used as a background control for all the samples measured. Trypan Blue
Exclusion assay was performed as previously described (13) . Briefly, cells were harvested and mixed with an equal volume of Trypan Blue dye. The number of live (appearing bright under light microscope) cells was then estimated from a total number of 200 cells from the harvested cells. The data were then analyzed using GraphPad Software.
